Crispr Therapeutics shares owned by NEA Management Company
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by NEA Management Company
from 13F filings
Historical chart of NEA Management Company investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by NEA Management Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by NEA Management Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $69M | 1.1M | 64.81 |
| 2025-06-30 | $77M | 1.6M | 48.64 |
| 2025-03-31 | $54M | 1.6M | 34.03 |
| 2024-12-31 | $63M | 1.6M | 39.36 |
| 2024-09-30 | $75M | 1.6M | 46.98 |
| 2024-06-30 | $86M | 1.6M | 54.01 |
| 2024-03-31 | $180M | 1.6M | 113.62 |
| 2023-12-31 | $99M | 1.6M | 62.60 |
| 2023-09-30 | $72M | 1.6M | 45.39 |
| 2023-06-30 | $89M | 1.6M | 56.14 |
| 2023-03-31 | $72M | 1.6M | 45.23 |
| 2022-12-31 | $65M | 1.6M | 40.65 |
| 2022-09-30 | $104M | 1.6M | 65.35 |
| 2022-06-30 | $97M | 1.6M | 60.77 |
| 2022-03-31 | $366M | 1.6M | 229.93 |
| 2021-12-31 | $121M | 1.6M | 75.78 |
| 2021-09-30 | $178M | 1.6M | 111.93 |
| 2021-06-30 | $257M | 1.6M | 161.89 |
| 2021-03-31 | $194M | 1.6M | 121.85 |
| 2020-12-31 | $243M | 1.6M | 153.11 |
| 2020-09-30 | $133M | 1.6M | 83.64 |
| 2020-06-30 | $154M | 2.1M | 73.49 |
| 2020-03-31 | $89M | 2.1M | 42.41 |
| 2019-12-31 | $127M | 2.1M | 60.90 |
| 2019-09-30 | $86M | 2.1M | 40.99 |
| 2019-06-30 | $99M | 2.1M | 47.10 |
| 2019-03-31 | $75M | 2.1M | 35.72 |
| 2018-12-31 | $60M | 2.1M | 28.57 |
| 2018-09-30 | $93M | 2.1M | 44.35 |
| 2018-06-30 | $123M | 2.1M | 58.76 |
| 2018-03-31 | $159M | 3.5M | 45.71 |
| 2017-12-31 | $76M | 3.2M | 23.48 |
| 2017-09-30 | $58M | 3.2M | 17.87 |
| 2017-06-30 | $52M | 3.2M | 16.02 |
| 2017-03-31 | $70M | 3.2M | 21.77 |
| 2016-12-31 | $65M | 3.2M | 20.26 |